These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2891390)

  • 1. Inflammatory bowel disease: the in vitro effect of sulphasalazine and other agents on prostaglandin synthesis by human rectal mucosa.
    Pacheco S; Hillier K; Smith CL
    Braz J Med Biol Res; 1987; 20(2):221-30. PubMed ID: 2891390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin catabolism and ulcerative colitis: effect of sulphasalazine, 5-aminosalicylic acid and other drugs.
    Pacheco S; Hillier K; Smith CL
    Braz J Med Biol Res; 1990; 23(12):1323-34. PubMed ID: 1983789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
    Sharon P; Ligumsky M; Rachmilewitz D; Zor U
    Gastroenterology; 1978 Oct; 75(4):638-40. PubMed ID: 30669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.
    Hillier K; Mason PJ; Pacheco S; Smith CL
    Br J Pharmacol; 1982 May; 76(1):157-61. PubMed ID: 6123357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prostaglandin synthetase in human rectal mucosa.
    Hawkey CJ; Lo Casto M
    Gut; 1983 Mar; 24(3):213-7. PubMed ID: 6131017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
    Peskar BM; Dreyling KW; Peskar BA; May B; Goebell H
    Agents Actions; 1986 Jun; 18(3-4):381-3. PubMed ID: 2875632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K; Hansen J; Bytzer P; Bukhave K; Rask-Madsen J
    Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine.
    Ligumsky M; Karmeli F; Sharon P; Zor U; Cohen F; Rachmilewitz D
    Gastroenterology; 1981 Sep; 81(3):444-9. PubMed ID: 6114012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flufenamic acid inhibition of PGE2 production by rectal mucosa in ulcerative colitis.
    Rachmilewitz D; Ligumsky M; Sharon P; Karmeli F; Zor U
    Gastroenterology; 1978 Nov; 75(5):929-30. PubMed ID: 29819
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between rectal mucosal prostaglandin production and water and electrolyte transport in ulcerative colitis.
    Rampton DS; Sladen GE
    Digestion; 1984; 30(1):13-22. PubMed ID: 6149163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis.
    Rampton DS; Sladen GE
    Scand J Gastroenterol; 1981; 16(1):157-9. PubMed ID: 6112788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.
    Hawkey CJ; Truelove SC
    Gut; 1981 Mar; 22(3):190-3. PubMed ID: 7227851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of prostaglandins and sulphasalazine in ulcerative colitis.
    Gould SR; Brash AR; Conolly ME; Lennard-Jones JE
    Prostaglandins Med; 1981 Feb; 6(2):165-82. PubMed ID: 6113614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of sulfasalazine, 5-aminosalicylic acid and sulfapyridine on prostanoid synthesis and metabolism in rabbit colonic mucosa.
    Kolassa N; Becker R; Wiener H
    Prostaglandins; 1985 Jan; 29(1):133-42. PubMed ID: 2858116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
    Eliakim R; Karmeli F; Razin E; Rachmilewitz D
    Gastroenterology; 1988 Nov; 95(5):1167-72. PubMed ID: 2901995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR; Moore PK
    Br J Pharmacol; 1980 Apr; 68(4):719-30. PubMed ID: 6103724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gut; 1987 Sep; 28(9):1095-9. PubMed ID: 2824300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.
    Rampton DS; Sladen GE
    Prostaglandins; 1981 Mar; 21(3):417-25. PubMed ID: 6112777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.
    Smith PR; Dawson DJ; Swan CH
    Gut; 1979 Sep; 20(9):802-5. PubMed ID: 40848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
    Schmidt C; Kosché E; Baumeister B; Vetter H
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.